Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Constipation after starting Saxenda is common as the medication slows gastric emptying and affects gut motility, and most cases respond well to hydration, higher fiber intake, regular movement, and a consistent bathroom routine.
Persistent or worsening symptoms after six weeks or accompanying pain, bleeding, bloating, or vomiting can be red flags that require medical evaluation, and there are several factors to consider. See below for the complete checklist and next steps.
Saxenda Constipation After Starting: Is It a Red Flag?
Starting Saxenda (liraglutide) can bring welcome weight-loss benefits—but also a new set of digestive changes. Constipation is one of the most commonly reported side effects. While for many people it's mild and manageable, sometimes it signals something more serious. This checklist will help you tell the difference and guide you on when to seek help.
Saxenda belongs to a class of medications called GLP-1 receptor agonists. It works by:
When you first start Saxenda, your system needs time to adapt. Many people report changes in bowel habits—constipation included—during the first few weeks.
If you've been on Saxenda for more than six weeks and still struggle, it's time to evaluate what else might be contributing and whether you need medical advice.
Try these first-line strategies before worrying about serious issues:
Stay hydrated
Aim for 8–10 glasses of water daily. Dehydration is a major cause of hard stools.
Boost fiber intake
Incorporate fruits, vegetables, whole grains, and legumes. If needed, add a fiber supplement (psyllium, inulin).
Move regularly
Even a daily 20-minute walk can stimulate bowel activity.
Establish a routine
Try to use the bathroom at the same time each day, especially after meals.
Over-the-counter options
Bulk-forming agents (e.g., Metamucil), osmotic laxatives (e.g., polyethylene glycol), or stool softeners can help. Always follow package directions.
If these steps don't bring relief within a week or symptoms worsen, consult a healthcare professional.
Use this checklist to decide if your constipation is still "mild and expected" or if it's time to seek immediate medical attention. Check any that apply:
If any of these apply, don't wait it out—these may be red flags for complications like bowel obstruction or severe impaction.
If you're unsure whether your symptoms require immediate attention, use this Medically approved LLM Symptom Checker Chat Bot to get personalized guidance based on your specific situation and help determine your next best step.
Call 911 or go to your nearest emergency department if you experience:
These symptoms could indicate a serious obstruction or another life-threatening GI issue.
Constipation after starting Saxenda is common, especially in the first few weeks. Most cases are mild and respond well to hydration, dietary tweaks, and over-the-counter remedies. However, persistent or severe symptoms—especially when paired with pain, bleeding, or vomiting—are red flags. Don't hesitate to:
Your health matters. Always reach out to a healthcare professional for personalized advice.
(References)
* Davies M, et al. Liraglutide 3.0 mg in combination with a reduced-calorie diet and increased physical activity for weight management in overweight and obese adults: a meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2015 Oct;17(10):973-81. doi: 10.1111/dom.12521. PMID: 26173091.
* Ji Z, et al. Adverse Event Profile of Liraglutide 3.0 mg for Weight Management: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Front Endocrinol (Lausanne). 2021 Jul 15;12:699026. doi: 10.3389/fendo.2021.699026. PMID: 34335508.
* Meng Z, et al. Gastrointestinal adverse events with GLP-1 receptor agonists for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015 Oct 29;10(10):e0141107. doi: 10.1371/journal.pone.0141107. PMID: 26513511.
* Tamez-Pérez HE, et al. Management of gastrointestinal side effects of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes. Expert Opin Drug Saf. 2020 Jan;19(1):97-107. doi: 10.1080/14740338.2020.1706689. PMID: 31872535.
* Mehta A, et al. Liraglutide for weight management: a critical review of the evidence. Expert Rev Clin Pharmacol. 2015 May;8(3):315-32. doi: 10.1586/17512433.2015.1026048. PMID: 25772648.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.